Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person12
Reformation Inc.
Company
CASS INFORMATION SYSTEMS INC
Company
Information Services Group Inc.
Company
AUTONATION, INC.
Company
7formation Ltd
Company · 06718528
ROCKWELL AUTOMATION, INC
Company
INFORMATION EDGE LIMITED
Company · 05337528
Nuvation Bio Inc.
Company
Infleqtion, Inc.
Company
ONTO INNOVATION INC.
Company
Joby Aviation, Inc.
Company
REVELATION BIOSCIENCES, INC.
Company
Primary record18
Onconetix, Inc. filed 8-K
Item 1.01 Entry into a Material Definitive Agreement. First Amendment to Share Exchange Agreement As previously disclosed, on February 11, 2026, Onconetix, Inc., a Delaware corporation (“ Onconetix ” or “ Buyer ”), enter
Pono Capital Four, Inc. filed 8-K
Item 1.01. Entry into a Material Definitive Agreement. As previously disclosed, on August 5, 2026, Pono Capital Four, Inc. (“Pono” or “Parent”), a Cayman Islands exempted company (which shall de-register from the Registe
Wheeler Real Estate Investment Trust, Inc. filed 8-K
Item 3.03. Material Modification to Rights of Security Holders Conversion Price of 7.00% Subordinated Convertible Notes due 2031 Item 8.01 of this Current Report on Form 8-K as to the redemptions by the holders of Wheele
Global Self Storage, Inc. filed 8-K
Item 2.02 Results of Operations and Financial Condition. On November 6, 2026, Global Self Storage, Inc. (the “Company”) reported its financial results for the period ended September 30, 2026. A copy of the Company’s earn
Knight-Swift Transportation Holdings Inc. filed 8-K
ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS Knight-Swift Appoints Richard Howard to the Board On November 4,
CURIS INC filed 8-K
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On November 2, 2026, Curis, Inc. (the “Company”) received a letter (the “Delist Determination Letter”) from
Acrivon Therapeutics, Inc. filed 8-K
Item 8.01 Other Events. On November 6, 2026, Acrivon Therapeutics, Inc., a Delaware corporation (the “ Company ”), announced that it has entered into an asset purchase agreement (the “ Purchase Agreement ”) with Aqilion
Enova International, Inc. filed 8-K
Item 7.01 Regulation FD Disclosure. On November 3, 2026, Enova International, Inc. (the “ Company ”) announced that a wholly-owned indirect subsidiary, OnDeck Asset Securitization IV, LLC (the “ Issuer ”), intends to off
TKO Group Holdings, Inc. filed 8-K
Item 8.01 Other Events. On November 5, 2026, TKO Group Holdings, Inc. (the “Company” or “TKO”) announced the commencement of an offering (the “Offering”) of $1.0 billion in aggregate principal amount of Senior Secured No
MOLINA HEALTHCARE, INC. filed 8-K
Item 7.01. Regulation FD Disclosure. 2026 Outlook Affirmation Members of the senior management team of Molina Healthcare, Inc. (“Molina” or the “Company”) will be participating in UBS’s Global Healthcare Conference on Mo
First Breach, Inc. filed 8-K
Item 7.01. Regulation FD Disclosure. On November 3, 2026, First Breach Inc. (the “Company”) issued a press release announcing certain supply agreements and equipment additions in support of the Company’s ammunition produ
Profusa, Inc. filed 8-K
Item 1.01. Entry into a Material Definitive Agreement. The information set forth under Item 2.03 below is hereby incorporated herein by reference. Item 2.03. Creation of a Direct Financial Obligation or an Obligation und
Strive, Inc. filed 8-K
Item 2.02. Results of Operations and Financial Condition. On November 6, 2026, Strive, Inc. (the “Company” or "Strive") issued a press release announcing the Company’s financial results for the quarter ended September 30
POWERCOMPUTE, INC. filed 8-K
Item 1.01 Entry into a Material Definitive Agreement. On November 2, 2026, PowerCompute Inc. (the “Company”) entered into a Fourth Amendment to Secured Promissory Note, effective October 31, 2026 (the “Note Amendment”),
TuHURA Biosciences, Inc./NV filed 8-K
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. As previously disclosed, on April 21, 2026, TuHURA Biosciences, Inc. (the “Company”) entered in
GeoVax Labs, Inc. filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers (b) Termination of President and Chief Executive Officer On Nove
INTRUSION INC filed 8-K
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On November 4, 2026, Intrusion Inc. (the “Company”) received formal written notification from the Listing Qua
NEXTERA ENERGY INC filed 8-K
Item 8.01 Other Events As previously disclosed in a Current Report on Form 8-K filed with the Securities and Exchange Commission (SEC) on May 18, 2026, on May 15, 2026, NextEra Energy, Inc., a Florida corporation (NEE),